propranolol has been researched along with Dyskinesia, Drug-Induced in 38 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In Parkinson's disease (PD), the long term use of L-DOPA results in major adverse effects including dyskinesia or abnormal involuntary movements." | 1.36 | The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. ( Buck, K; Ferger, B, 2010) |
| "Progress in the treatment of action myoclonus is especially noteworthy and has led to the implication of serotonin deficit in the pathophysiology of this syndrome." | 1.26 | New approaches in the management of hyperkinetic movement disorders. ( Fahn, S, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (73.68) | 18.7374 |
| 1990's | 7 (18.42) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (7.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhide, N | 2 |
| Lindenbach, D | 2 |
| Barnum, CJ | 2 |
| George, JA | 1 |
| Surrena, MA | 2 |
| Bishop, C | 2 |
| Buck, K | 1 |
| Ferger, B | 1 |
| Goldenberg, AA | 1 |
| Tignor, S | 1 |
| Klioueva, A | 1 |
| Walters, H | 1 |
| Bacher, NM | 1 |
| Lewis, HA | 2 |
| Kulik, FA | 2 |
| Wilbur, R | 3 |
| Chaudhry, R | 1 |
| Radonjic, D | 1 |
| Waters, B | 1 |
| Schrodt, GR | 1 |
| Wright, JH | 1 |
| Simpson, R | 1 |
| Moore, DP | 1 |
| Chase, S | 1 |
| Kurlan, R | 1 |
| Shoulson, I | 1 |
| Perényi, A | 1 |
| Farkas, A | 1 |
| Bacher, NA | 1 |
| Karniol, IG | 1 |
| Portela, W | 1 |
| Lipinski, JF | 1 |
| Zubenko, GS | 1 |
| Barreira, P | 1 |
| Cohen, BM | 1 |
| Kulik, AV | 1 |
| Kuehnle, JC | 1 |
| Johnson, JM | 1 |
| Ratey, JJ | 1 |
| Salzman, C | 1 |
| Olivera, AA | 1 |
| Kiefer, MW | 1 |
| Pitts, FN | 1 |
| Einarson, TR | 1 |
| Risch, SC | 1 |
| Cohen, RM | 1 |
| Kalin, NH | 1 |
| Roberts, PW | 1 |
| Sachdev, P | 2 |
| Loneragan, C | 1 |
| Metzer, WS | 1 |
| Paige, SR | 1 |
| Newton, JE | 1 |
| Kalian, M | 1 |
| Lerner, V | 1 |
| Goldman, M | 1 |
| Ahlskog, JE | 1 |
| Shamrakov, O | 1 |
| Berner, Y | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Nohria, V | 1 |
| Owen, RT | 1 |
| Snyder, SH | 1 |
| Fahn, S | 1 |
| Adler, LA | 1 |
| Angrist, B | 1 |
| Rotrosen, J | 1 |
| Chee, KY | 1 |
| Frost, L | 1 |
| Lal, S | 1 |
| Yassa, R | 1 |
| Cooper, SJ | 1 |
| Doherty, MM | 1 |
| King, DJ | 1 |
| Petit, H | 1 |
| Catteau, J | 1 |
| Dumon, JP | 1 |
| Libert, C | 1 |
| Gelenberg, AJ | 1 |
| Novac, A | 1 |
| Sandyk, R | 1 |
5 reviews available for propranolol and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Up and down regulation: clinical significance of nervous system receptor-drug interactions.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Humans; Nervo | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Medical treatment of later-stage motor problems of Parkinson disease.
Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; | 1999 |
Receptors, neurotransmitters and drug responses.
Topics: Animals; Antipsychotic Agents; Behavior; Brain Chemistry; Cyclic AMP; Dyskinesia, Drug-Induced; Enke | 1979 |
Treating extrapyramidal reactions: some current issues.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans | 1987 |
7 trials available for propranolol and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Femal | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Intravenous benztropine and propranolol challenges in tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Benztropine; Cross-Over Studies; Double-Blind Method; Dyski | 1993 |
Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Dyskine | 1993 |
Metoprolol versus propranolol.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Metoprolol; Middle Aged; Neurologic E | 1990 |
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztr | 1990 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
27 other studies available for propranolol and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.
Topics: Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Co | 2015 |
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 2010 |
Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenergic Neurons; Animals; Behavior, An | 2012 |
Low-dose propranolol in tardive dyskinesia.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Male; Midd | 1980 |
Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease, Second | 1980 |
Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Humans; | 1980 |
Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Drug Therapy, Combination; Dys | 1982 |
Treatment of tardive dyskinesia with propranolol.
Topics: Adult; Aged; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Ma | 1982 |
Propranolol in the treatment of tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Prop | 1983 |
Propranolol, anxiety, and tardive dyskinesia.
Topics: Antipsychotic Agents; Anxiety; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Proprano | 1983 |
Propranolol in the treatment of neuroleptic-induced akathisia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Propranolol; Restless Legs Syndrome | 1983 |
Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Ind | 1983 |
Neuroleptic-induced akathisia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Propranolol | 1983 |
Recognizing and managing akathisia.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Ben | 1984 |
Propranolol therapy in a patient with panic disorder, tardive dyskinesia, and essential tremor.
Topics: Adult; Anxiety Disorders; Dyskinesia, Drug-Induced; Fear; Humans; Male; Panic; Propranolol; Tremor | 1984 |
Treatment of tardive dyskinesia with propranolol.
Topics: Dyskinesia, Drug-Induced; Humans; Propranolol | 1982 |
Use of propranolol in treating tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Humans; Propranolol | 1981 |
Propranolol, chlorpromazine, and tardive dyskinesia.
Topics: Biological Availability; Chlorpromazine; Drug Interactions; Dyskinesia, Drug-Induced; Propranolol | 1980 |
The use of propranolol in treating tardive dyskinesia.
Topics: Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Propranolol | 1980 |
Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; | 1993 |
Response of elderly women with thyrotoxicosis to treatment for tardive dyskinesia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 1999 |
Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers.
Topics: Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Mice; Motor Acti | 1978 |
New approaches in the management of hyperkinetic movement disorders.
Topics: 5-Hydroxytryptophan; Carbidopa; Chorea; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Myoclo | 1977 |
Neuroleptic-induced marching-in-place.
Topics: Adult; Antipsychotic Agents; Benztropine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Humans; | 1989 |
[Treatment of akathisia of neuroleptics by propranolol].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Propranolol | 1985 |
Improvement in tardive dyskinesia and MMPI scores with propranolol.
Topics: Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; MMPI; Propranolol; Psychotic Disorders | 1986 |
Propranolol-induced tardive dyskinesia in a patient with akathisia.
Topics: Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Middle Aged; Parkinson Disease, Secondary; Pr | 1985 |